Why One Wealth Manager Turned This 5 Million Asset Manager Holding Into His Largest Holding

Why One Wealth Manager Turned This $155 Million Asset Manager Holding Into His Largest Holding

Schneider Downs Wealth Management Advisors increased its position in Federated Hermes (NYSE: FHI) during the first quarter, acquiring an estimated $3.56 million worth of shares based on the quarterly average price, according to a May 14, 2026, SEC filing. What happened According to a Securities and Exchange Commission (SEC) filing on May 14, 2026, Schneider…

Read More
As Terns shares soar 1,400%, what does a fund’s .2 million sale tell investors?

As Terns shares soar 1,400%, what does a fund’s $5.2 million sale tell investors?

On February 17, 2026, Acorn Capital Advisors reported the sale of 225,000 shares of Terns Pharmaceuticals (NASDAQ:TERN)an estimated trade of $5.20 million based on the quarterly average price. According to a filing with the Securities and Exchange Commission on February 17, 2026, Acorn Capital Advisors reduced its position in Terns Pharmaceuticals (NASDAQ:TERN) for 225,000 shares…

Read More
Immunovant Shares Soared 30% As Investor Trimmed His Stake By  Million, But Here’s Why It Still Looks Bullish

Immunovant Shares Soared 30% As Investor Trimmed His Stake By $3 Million, But Here’s Why It Still Looks Bullish

On February 17, 2026, Alpine Global Management disclosed a sale of 127,039 shares of immunovant (NASDAQ:IMVT)with an estimated transaction value of $2.83 million based on the quarterly average price. According to a filing with the Securities and Exchange Commission on February 17, 2026, Alpine Global Management reduced its position in Immunovant by 127,039 shares during…

Read More
Rockport Wealth buys  million from AIRR

Rockport Wealth buys $9 million from AIRR

On February 5, 2026, Rockport Wealth LLC disclosed a new position in First Trust RBA American Industrial Renaissance ETF (NASDAQ: AIR). According to a Securities and Exchange Commission (SEC) filing on February 5, 2026, Rockport Wealth LLC opened a new position in the First Trust RBA American Industrial Renaissance ETF by purchasing 97,377 shares. The…

Read More
Spyre Therapeutics Shares Rise Last Year as .5 Million Purchase Raises Stake to  Million

Spyre Therapeutics Shares Rise Last Year as $10.5 Million Purchase Raises Stake to $78 Million

Commodore Capital announced the purchase of 400,161 shares of Spyre Therapeutics (NASDAQ:SYRE)an estimated trade of $10.46 million based on quarterly average price, according to an SEC filing dated February 17, 2026. According to an SEC filing dated February 17, 2026, Commodore Capital increased its position in Spyre Therapeutics by 400,161 shares during the fourth quarter….

Read More
Apogee Shares Are Up Nearly 100% in 12 Months, and This  Million Purchase Indicates Continued Conviction

Apogee Shares Are Up Nearly 100% in 12 Months, and This $62 Million Purchase Indicates Continued Conviction

On February 17, 2026, Perceptive Advisors revealed a purchase of 978,662 shares of Apogee Therapeutics (NASDAQ: APGE)with an estimated transaction value of $61.64 million based on the quarterly average price. According to a February 17, 2026 SEC filing, Perceptive Advisors increased its stake in Apogee Therapeutics (NASDAQ: APGE) for 978,662 shares. The estimated value of…

Read More